GlobalData’s clinical trial report, “Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2013” provides data on the Gouty Arthritis (Gout) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gouty Arthritis (Gout). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gouty Arthritis (Gout). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Gouty Arthritis (Gout) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by BRIC Nations 15

Clinical Trials by G7 Nations 16

Clinical Trials in G7 Nations by Trial Status 17

Clinical Trials by E7 Nations 18

Clinical Trials in E7 Nations by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Unaccomplished Trials of Gouty Arthritis (Gout) 23

Subjects Recruited Over a Period of Time 25

Prominent Sponsors 26

Top Companies Participating in Gouty Arthritis (Gout) Therapeutics Clinical Trials 28

Prominent Drug Comparison 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

AstraZeneca PLC 31

Clinical Trial Overview of AstraZeneca PLC 31

Takeda Pharmaceutical Company Limited 32

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 32

Novartis AG 33

Clinical Trial Overview of Novartis AG 33

Mutual Pharmaceutical Company, Inc. 35

Clinical Trial Overview of Mutual Pharmaceutical Company, Inc. 35

Regeneron Pharmaceuticals, Inc. 36

Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 36

Savient Pharmaceuticals, Inc. 37

Clinical Trial Overview of Savient Pharmaceuticals, Inc. 37

Fuji Yakuhin Co., Ltd. 38

Clinical Trial Overview of Fuji Yakuhin Co., Ltd. 38

Sanwa Kagaku Kenkyusho Co., Ltd. 39

Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd. 39

BioCryst Pharmaceuticals, Inc. 40

Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 40

Metabolex, Inc 41

Clinical Trial Overview of Metabolex, Inc 41

Clinical Trial Overview of Top Institutes / Government 42

Zhejiang University 42

Clinical Trial Overview of Zhejiang University 42

Royal Perth Hospital 43

Clinical Trial Overview of Royal Perth Hospital 43

The University of Mississippi Medical Center 44

Clinical Trial Overview of The University of Mississippi Medical Center 44

University of Otago 45

Clinical Trial Overview of University of Otago 45

University of Toronto 46

Clinical Trial Overview of University of Toronto 46

The University of Nottingham 47

Clinical Trial Overview of The University of Nottingham 47

St Vincent's Hospital Sydney 48

Clinical Trial Overview of St Vincent's Hospital Sydney 48

The Medical Center Leeuwarden 49

Clinical Trial Overview of The Medical Center Leeuwarden 49

Midorigaoka Hospital 50

Clinical Trial Overview of Midorigaoka Hospital 50

Kobe University 51

Clinical Trial Overview of Kobe University 51

Five Key Clinical Profiles 52

Appendix 139

Abbreviations 139

Definitions 139

Research Methodology 140

Secondary Research 140

About GlobalData 141

Contact Us 141

Disclaimer 141

Source 142

List of Tables

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11

Gouty Arthritis (Gout) Therapeutics Clinical Trials, North America, Top Countries, 2013* 12

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14

Gouty Arthritis (Gout) Therapeutics Clinical Trials, BRIC Countries, 2013* 15

Gouty Arthritis (Gout) Therapeutics Clinical Trials, G7 Countries, 2013* 16

Gouty Arthritis (Gout) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17

Gouty Arthritis (Gout) Therapeutics Clinical Trials, E7 Countries, 2013* 18

Gouty Arthritis (Gout) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22

Gouty Arthritis (Gout) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23

Gouty Arthritis (Gout) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 30

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 31

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 32

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 33

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mutual Pharmaceutical Company, Inc., 2013* 35

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2013* 36

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Savient Pharmaceuticals, Inc., 2013* 37

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fuji Yakuhin Co., Ltd., 2013* 38

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanwa Kagaku Kenkyusho Co., Ltd., 2013* 39

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2013* 40

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Metabolex, Inc, 2013* 41

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhejiang University, 2013* 42

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Perth Hospital, 2013* 43

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Mississippi Medical Center, 2013* 44

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Otago, 2013* 45

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 46

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2013* 47

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by St Vincent's Hospital Sydney, 2013* 48

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical Center Leeuwarden, 2013* 49

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Midorigaoka Hospital, 2013* 50

Gouty Arthritis (Gout) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2013* 51

List of Figures

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11

Gouty Arthritis (Gout) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14

Gouty Arthritis (Gout) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15

Gouty Arthritis (Gout) Therapeutics Clinical Trials, G7 Countries (%), 2013* 16

Gouty Arthritis (Gout) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17

Gouty Arthritis (Gout) Therapeutics Clinical Trials, E7 Countries (%), 2013* 18

Gouty Arthritis (Gout) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21

Gouty Arthritis (Gout) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28

Gouty Arthritis (Gout) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 30

GlobalData Methodology 140